It undermines the negotiation entirely.
Editor's note · Context
Wyden points out how payment structures affect drug price negotiations.
Share & report
More from Ron Wyden
Mr. President, 4 years ago, I kicked off an investigation of Big Pharma's tax practices, the dodges and tricks these hugely profitable, multinational companies use to winnow down their tax bills. This was not very long after Trump's first…
Mr. President, I listened very carefully to my colleague from Alabama, and I don't believe my colleague used the word ``fentanyl,'' and that is what we are concerned about in the Pacific Northwest. We are concerned that fentanyl has hit…
Mr. President, first of all, I want it understood that we take a backseat to nobody--nobody--when it comes to fighting this fraud. That is why I negotiated a bipartisan package in the last Congress dealing with a host of issues relating to…





